Noriaki Sugawara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noriaki Sugawara has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Taro Iwatsubo
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Takatsuki Osaka Japan
9 shared publications - Kazuhiro Ota
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Osaka Japan
7 shared publications Hiroki Nishikawa
Osaka Medical and Pharmaceutical University, Osaka Prefecture, Japan
6 shared publicationsShun Sasaki
Osaka Medical and Pharmaceutical University Hospital, Osaka Prefecture, Japan
6 shared publications- Akitoshi Hakoda
2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
4 shared publications Hironori Tanaka
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Osaka Japan
4 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1124-E1125
Cap-assisted photodynamic therapy for esophageal cancer: precise irradiation field control for tumor-confined treatment
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1124-E1125
Open AccessCap-assisted photodynamic therapy for esophageal cancer: precise irradiation field control for tumor-confined treatment
- Open Access
Endoscopic Injection Sclerotherapy With Pre‐deflation Ligation for Prolonged Sclerosant Retention in Esophageal Varices: A Case Report
Esophageal varices are a common complication of portal hypertension, and prophylactic endoscopic injection sclerotherapy with ligation (EISL) is an established treatment option. Effective variceal thrombosis requires sufficient intravariceal retention of the sclerosant, because ethanolamine oleate exerts its thrombogenic effect through prolonged contact with the venous endothelium. In conventional EISL, endoscopic variceal ligation (EVL) is performed after balloon deflation, leaving a transient interval during which restored blood flow and an open puncture site may permit washout of the sclerosant and bleeding. We describe EIS with pre‐deflation ligation (EISpdL), in which EVL of the puncture site is completed while the endoscope balloon remains inflated, and balloon compression is maintained throughout the retention period. A 59‐year‐old man with medium‐sized esophageal varices with a positive red color sign (F2, RC1) secondary to metabolic dysfunction‐associated steatohepatitis underwent EISpdL combined with gel‐immersion EIS. The procedure was technically feasible, required no additional skills beyond conventional EISL, and no immediate procedure‐related adverse events were observed. Follow‐up endoscopy on post‐procedure day 7 showed bronze‐colored variceal changes indicating thrombosis, and contrast‐enhanced computed tomography two months later confirmed obliteration. EISpdL may enable more stable and prolonged sclerosant retention.
Open AccessEndoscopic Injection Sclerotherapy With Pre‐deflation Ligation for Prolonged Sclerosant Retention in Esophageal Varices: A Case Report
Esophageal varices are a common complication of portal hypertension, and prophylactic endoscopic injection sclerotherapy with ligation (EISL) is an established treatment option. Effective variceal thrombosis requires sufficient intravariceal retention of the sclerosant, because ethanolamine oleate exerts its thrombogenic effect through prolonged contact with the venous endothelium. In conventional EISL, endoscopic variceal ligation (EVL) is performed after balloon deflation, leaving a transient interval during which restored blood flow and an open puncture site may permit washout of the sclerosant and bleeding. We describe EIS with pre‐deflation ligation (EISpdL), in which EVL of the puncture site is completed while the endoscope balloon remains inflated, and balloon compression is maintained throughout the retention period. A 59‐year‐old man with medium‐sized esophageal varices with a positive red color sign (F2, RC1) secondary to metabolic dysfunction‐associated steatohepatitis underwent EISpdL combined with gel‐immersion EIS. The procedure was technically feasible, required no additional skills beyond conventional EISL, and no immediate procedure‐related adverse events were observed. Follow‐up endoscopy on post‐procedure day 7 showed bronze‐colored variceal changes indicating thrombosis, and contrast‐enhanced computed tomography two months later confirmed obliteration. EISpdL may enable more stable and prolonged sclerosant retention.
- Open Access
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70458
Small Bowel Obstruction Possibly Related to Migration of Trichobezoar Fragments Following Endoscopic Treatment
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70458
Open AccessSmall Bowel Obstruction Possibly Related to Migration of Trichobezoar Fragments Following Endoscopic Treatment
- Open Access
Successful perforation management during esophageal endoscopic submucosal dissection using the stent‐anchoring method: A case report
Patients with esophageal endoscopic submucosal dissection‐associated adverse events can have a severe clinical course. In this report, we describe the case of a 67‐year‐old male with a history of endoscopic submucosal dissection who had metachronous superficial esophageal cancer. Although endoscopic submucosal dissection was attempted for challenging lesions adjacent to the scar, perforations occurred during the procedure. We placed an esophageal fully covered self‐expandable metallic stent at the perforation site to avoid emergency surgery after lesion removal. However, stent migration and displacement concerns remained, as no stenosis was observed in the esophagus. Therefore, a clip with a thread on the upper edge of the stent was placed, and this anchoring clip was useful in preventing stent migration and closing the perforation. The patient improved with conservative treatment. In conclusion, the stent placement and anchoring method with clip and thread could be a treatment option in such cases.
Open AccessSuccessful perforation management during esophageal endoscopic submucosal dissection using the stent‐anchoring method: A case report
Patients with esophageal endoscopic submucosal dissection‐associated adverse events can have a severe clinical course. In this report, we describe the case of a 67‐year‐old male with a history of endoscopic submucosal dissection who had metachronous superficial esophageal cancer. Although endoscopic submucosal dissection was attempted for challenging lesions adjacent to the scar, perforations occurred during the procedure. We placed an esophageal fully covered self‐expandable metallic stent at the perforation site to avoid emergency surgery after lesion removal. However, stent migration and displacement concerns remained, as no stenosis was observed in the esophagus. Therefore, a clip with a thread on the upper edge of the stent was placed, and this anchoring clip was useful in preventing stent migration and closing the perforation. The patient improved with conservative treatment. In conclusion, the stent placement and anchoring method with clip and thread could be a treatment option in such cases.
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1357-E1358
Endoscopic closure of a refractory gastric fistula using a novel cap-assisted poly-glycolic acid sheet application method
Gastrointestinal perforations and fistulas are severe conditions requiring prompt treatment. Endoscopic closure of fistulas using a polyglycolic acid (PGA) sheet (Neoveal; Gunze Co., Kyoto, Japan) with fibrin glue is minimally invasive and effective treatment for these conditions [1] [2] [3]. However, for fistulas caused by peptic ulcers, it is desirable to cover not only the perforation but also the surrounding ulcerated area with a large sheet. The conventional method of PGA sheet application through the accessory channel of the endoscope for fistula closure is relatively simple; however, deploying the sheet endoscopically within the gastrointestinal tract can be time-consuming due to the difficulty in maintaining its planar shape. Patients with gastrointestinal perforations or fistulas often present in poor general conditions, necessitating rapid wound closure. To address this challenge, we developed the “Cap-PGA method (CPM),” a novel PGA sheet application technique utilizing a cap attached to the endoscope tip ([Fig. 1]). The CPM facilitates the release of the sheet that remains fully expanded within the gastrointestinal tract, thereby simplifying deployment and significantly reducing the procedural time. This method is also adaptable to larger sheets. We report the case of a 71-year-old female with a refractory gastric fistula secondary to a drug-induced gastric ulcer perforation, which was successfully closed using CPM ([Video 1]). The patient was undergoing immunosuppressive therapy. She developed a drug-induced gastric ulcer perforation, which was initially managed conservatively but resulted in a persistent fistula ([Fig. 2]). Conventional endoscopic PGA sheet application was attempted but failed because of dislodgement. Alternatively, we attempted to use the CPM. The PGA sheet was grasped using forceps passed through the working channel of the endoscope and positioned to cover the cap attached to the scope tip. The scope was then blindly introduced into the stomach, and the sheet was released. The sheet maintained its fully expanded shape upon release, allowing for easy application to the ulcer base and fistula ([Fig. 3], [Fig. 4]). No procedure-related complications occurred. The total procedural time from scope insertion to withdrawal was approximately 6 min. Ten days after the procedure, endoscopic contrast examination confirmed the successful closure of the fistula. CPM allows for rapid and relatively simple coverage of fistulas with PGA sheets. This technique may be an effective treatment, especially for ulcers, fistulas, and perforations that require larger PGA sheets. Endoscopy_UCTN_Code_TTT_1AO_2AI Article published online: 26 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1357-E1358
Open AccessEndoscopic closure of a refractory gastric fistula using a novel cap-assisted poly-glycolic acid sheet application method
Gastrointestinal perforations and fistulas are severe conditions requiring prompt treatment. Endoscopic closure of fistulas using a polyglycolic acid (PGA) sheet (Neoveal; Gunze Co., Kyoto, Japan) with fibrin glue is minimally invasive and effective treatment for these conditions [1] [2] [3]. However, for fistulas caused by peptic ulcers, it is desirable to cover not only the perforation but also the surrounding ulcerated area with a large sheet. The conventional method of PGA sheet application through the accessory channel of the endoscope for fistula closure is relatively simple; however, deploying the sheet endoscopically within the gastrointestinal tract can be time-consuming due to the difficulty in maintaining its planar shape. Patients with gastrointestinal perforations or fistulas often present in poor general conditions, necessitating rapid wound closure. To address this challenge, we developed the “Cap-PGA method (CPM),” a novel PGA sheet application technique utilizing a cap attached to the endoscope tip ([Fig. 1]). The CPM facilitates the release of the sheet that remains fully expanded within the gastrointestinal tract, thereby simplifying deployment and significantly reducing the procedural time. This method is also adaptable to larger sheets. We report the case of a 71-year-old female with a refractory gastric fistula secondary to a drug-induced gastric ulcer perforation, which was successfully closed using CPM ([Video 1]). The patient was undergoing immunosuppressive therapy. She developed a drug-induced gastric ulcer perforation, which was initially managed conservatively but resulted in a persistent fistula ([Fig. 2]). Conventional endoscopic PGA sheet application was attempted but failed because of dislodgement. Alternatively, we attempted to use the CPM. The PGA sheet was grasped using forceps passed through the working channel of the endoscope and positioned to cover the cap attached to the scope tip. The scope was then blindly introduced into the stomach, and the sheet was released. The sheet maintained its fully expanded shape upon release, allowing for easy application to the ulcer base and fistula ([Fig. 3], [Fig. 4]). No procedure-related complications occurred. The total procedural time from scope insertion to withdrawal was approximately 6 min. Ten days after the procedure, endoscopic contrast examination confirmed the successful closure of the fistula. CPM allows for rapid and relatively simple coverage of fistulas with PGA sheets. This technique may be an effective treatment, especially for ulcers, fistulas, and perforations that require larger PGA sheets. Endoscopy_UCTN_Code_TTT_1AO_2AI Article published online: 26 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
Novel gel‐immersion endoscopic injection sclerotherapy method for prophylactic hemostasis of esophageal varices: A pilot feasibility and safety study (with video)
Endoscopic injection sclerotherapy (EIS) is a useful prophylactic hemostatic procedure for esophageal varices. However, injecting sclerosing agents into blood vessels is technically challenging and often ineffective. Gel‐immersion EIS (GI‐EIS) may facilitate easier intravascular sclerosing agent injection by dilating the varices and enhancing scope stability by maintaining low intra‐gastrointestinal pressure. Therefore, we aimed to evaluate the effectiveness and safety of this procedure. This retrospective study included 18 patients (14 men and four women; median age, 70 years; age range, 18–83 years) who underwent GI‐EIS at Osaka Medical Pharmaceutical University Hospital between December 1, 2022, and January 30, 2024. Patients who were at least 18 years of age at the time of treatment were included. No patients were excluded from the study. Thirty‐four punctures were performed. The donor vessel angiography success rate was 88.2% (30 of 34 punctures). The clinical success rate was 94.4% (17 of 18 patients). Esophageal varices in most patients disappeared or were reduced by 1 month after treatment. Adverse events related to the procedure included fever (three patients) and chest pain (one patient); however, both were resolved with conservative treatment. No respiratory deterioration due to aspiration occurred during the procedure. The results of this study demonstrate that GI‐EIS is a safe, clinically feasible, and effective treatment option for prophylactic hemostasis of esophageal varices.
Open AccessNovel gel‐immersion endoscopic injection sclerotherapy method for prophylactic hemostasis of esophageal varices: A pilot feasibility and safety study (with video)
Endoscopic injection sclerotherapy (EIS) is a useful prophylactic hemostatic procedure for esophageal varices. However, injecting sclerosing agents into blood vessels is technically challenging and often ineffective. Gel‐immersion EIS (GI‐EIS) may facilitate easier intravascular sclerosing agent injection by dilating the varices and enhancing scope stability by maintaining low intra‐gastrointestinal pressure. Therefore, we aimed to evaluate the effectiveness and safety of this procedure. This retrospective study included 18 patients (14 men and four women; median age, 70 years; age range, 18–83 years) who underwent GI‐EIS at Osaka Medical Pharmaceutical University Hospital between December 1, 2022, and January 30, 2024. Patients who were at least 18 years of age at the time of treatment were included. No patients were excluded from the study. Thirty‐four punctures were performed. The donor vessel angiography success rate was 88.2% (30 of 34 punctures). The clinical success rate was 94.4% (17 of 18 patients). Esophageal varices in most patients disappeared or were reduced by 1 month after treatment. Adverse events related to the procedure included fever (three patients) and chest pain (one patient); however, both were resolved with conservative treatment. No respiratory deterioration due to aspiration occurred during the procedure. The results of this study demonstrate that GI‐EIS is a safe, clinically feasible, and effective treatment option for prophylactic hemostasis of esophageal varices.
- Open Access
- 4 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (06) , E769-E771
The “Dumpling method:” Novel technique for preventing PuraStat migration and enhancing hemostasis
Received: 06 March 2024 Accepted after revision: 25 April 2024 Article published online: 20 June 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (06) , E769-E771
Open AccessThe “Dumpling method:” Novel technique for preventing PuraStat migration and enhancing hemostasis
Received: 06 March 2024 Accepted after revision: 25 April 2024 Article published online: 20 June 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 01) , E926-E927
A novel method, gel immersion endoscopic injection sclerotherapy, may make the procedure easier and more accurate
Esophageal varices are caused by portal hypertension such as cirrhosis. Ruptured esophageal varices cause massive bleeding; therefore, preventive hemostasis is important. The standard procedures to prevent bleeding include endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS). EIS is a more difficult procedure than EVL but results in a lower recurrence rate and is more curative. In particular, problems are often faced in the process of inserting a needle into esophageal varices and injecting sclerosing agents into the vessel. Gel immersion endoscopy is a useful method for securing a visual field [1]. Additionally, a lower level of intraluminal pressure and wall tension is maintained [2] and the vessel lumen is kept thicker and wider than that during gas emersion ([Fig. 1]). Therefore, EIS with a “Viscoclear” gel (Otsuka Pharmaceutical Factory, Tokushima, Japan) may allow easier needle insertion and sclerosing material injection into esophageal varices. Herein, a 73-year-old man was admitted to a psychiatric hospital for schizophrenia. Upper gastrointestinal endoscopy revealed F2 or larger esophageal varices that required treatment, and he was transferred to our hospital for prophylactic hemostasis ([Video 1]). We performed EIS of the esophageal varices using gel immersion endoscopy. Under the gel, the vessels were thicker due to the lower pressure in the esophageal lumen ([Fig. 2]), and ultrasound endoscopy confirmed that the vascular lumen remained circular ([Fig. 3]). We were able to puncture the vessel under the gel and inject sufficient sclerosing agent. A total of 600 mL of gel was used and the procedure time was 4 min. No irrigation accessories were used. Gel-immersion EIS may be useful as it makes the puncture process easier and more accurate. Video 1 Gel-immersion endoscopic injection sclerotherapy (EIS) may be useful because it makes the puncture process easier and more accurate. Endoscopy_UCTN_Code_CCL_1AB_2AC_3AG Article published online: 27 July 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 01) , E926-E927
Open AccessA novel method, gel immersion endoscopic injection sclerotherapy, may make the procedure easier and more accurate
Esophageal varices are caused by portal hypertension such as cirrhosis. Ruptured esophageal varices cause massive bleeding; therefore, preventive hemostasis is important. The standard procedures to prevent bleeding include endoscopic variceal ligation (EVL) and endoscopic injection sclerotherapy (EIS). EIS is a more difficult procedure than EVL but results in a lower recurrence rate and is more curative. In particular, problems are often faced in the process of inserting a needle into esophageal varices and injecting sclerosing agents into the vessel. Gel immersion endoscopy is a useful method for securing a visual field [1]. Additionally, a lower level of intraluminal pressure and wall tension is maintained [2] and the vessel lumen is kept thicker and wider than that during gas emersion ([Fig. 1]). Therefore, EIS with a “Viscoclear” gel (Otsuka Pharmaceutical Factory, Tokushima, Japan) may allow easier needle insertion and sclerosing material injection into esophageal varices. Herein, a 73-year-old man was admitted to a psychiatric hospital for schizophrenia. Upper gastrointestinal endoscopy revealed F2 or larger esophageal varices that required treatment, and he was transferred to our hospital for prophylactic hemostasis ([Video 1]). We performed EIS of the esophageal varices using gel immersion endoscopy. Under the gel, the vessels were thicker due to the lower pressure in the esophageal lumen ([Fig. 2]), and ultrasound endoscopy confirmed that the vascular lumen remained circular ([Fig. 3]). We were able to puncture the vessel under the gel and inject sufficient sclerosing agent. A total of 600 mL of gel was used and the procedure time was 4 min. No irrigation accessories were used. Gel-immersion EIS may be useful as it makes the puncture process easier and more accurate. Video 1 Gel-immersion endoscopic injection sclerotherapy (EIS) may be useful because it makes the puncture process easier and more accurate. Endoscopy_UCTN_Code_CCL_1AB_2AC_3AG Article published online: 27 July 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 July 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (6) , E141-E142
Endoscopic hemostasis of an active hypopharyngeal hemorrhage via gel immersion endoscopy
Watch a video of this article.
- 26 July 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (6) , E141-E142
Endoscopic hemostasis of an active hypopharyngeal hemorrhage via gel immersion endoscopy
Watch a video of this article.
- Open Access
- 8 January 2019
- Published by Springer Nature in BMC Gastroenterology
- Vol. 19 (1) , 4
Preventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study
We aimed to investigate how high-dose ecabet sodium affects low-dose aspirin-induced small intestinal mucosal injury in healthy volunteers. Healthy volunteers were enrolled randomly into one of two groups with the following drug regimens for 2 weeks: group A, low-dose aspirin once per day and group B, low-dose aspirin and 4.0 g of ecabet sodium. Small bowel capsule endoscopy was performed before and 2 weeks after low-dose aspirin administration. A significant difference was found in the median number [range] of small intestinal lesions between baseline and two weeks after low-dose aspirin administration in group A (baseline: 1 [0–5], after: 5 [1–11]; p = 0.0059) but not in group B (baseline: 0.5 [0–9], after: 3 [0–23]; p = 0.0586). In group B, although the median number [range] of lesions in the first tertile of the small intestine did not increase two weeks after low-dose aspirin administration (baseline: 0 [0–4], after: 1.5 [0–8]; p = 0.2969), the number of lesions in the second and third tertiles of the small intestine increased significantly (baseline: 0 [0–5], after: 2 [0–15]; p = 0.0469). Ecabet sodium had a preventive effect on low-dose aspirin-induced small intestinal mucosal injury in the upper part of the small intestine. ISRCTN 99322160 , 01/10/2018.
- 8 January 2019
- Published by Springer Nature in BMC Gastroenterology
- Vol. 19 (1) , 4
Open AccessPreventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study
We aimed to investigate how high-dose ecabet sodium affects low-dose aspirin-induced small intestinal mucosal injury in healthy volunteers. Healthy volunteers were enrolled randomly into one of two groups with the following drug regimens for 2 weeks: group A, low-dose aspirin once per day and group B, low-dose aspirin and 4.0 g of ecabet sodium. Small bowel capsule endoscopy was performed before and 2 weeks after low-dose aspirin administration. A significant difference was found in the median number [range] of small intestinal lesions between baseline and two weeks after low-dose aspirin administration in group A (baseline: 1 [0–5], after: 5 [1–11]; p = 0.0059) but not in group B (baseline: 0.5 [0–9], after: 3 [0–23]; p = 0.0586). In group B, although the median number [range] of lesions in the first tertile of the small intestine did not increase two weeks after low-dose aspirin administration (baseline: 0 [0–4], after: 1.5 [0–8]; p = 0.2969), the number of lesions in the second and third tertiles of the small intestine increased significantly (baseline: 0 [0–5], after: 2 [0–15]; p = 0.0469). Ecabet sodium had a preventive effect on low-dose aspirin-induced small intestinal mucosal injury in the upper part of the small intestine. ISRCTN 99322160 , 01/10/2018.